M&A

Cordis Is Involved in M&A, But Not in the Way You Might Think
Medical Devices and Diagnostics Industry
Mon, 10/2/23 - 06:32 pm
Cordis
M&A
medtehc
MedAlliance
Alfasigma To Acquire Intercept Pharma For $19 Per Share In Cash
RTT News
Tue, 09/26/23 - 10:13 am
Intercept Pharma
M&A
Alfasigma
NASH
Enovis inks €800M deal for Italian orthopedics player Lima
Fierce Biotech
Mon, 09/25/23 - 07:51 pm
Enovis
Medtech
M&A
Orthopedics
Lima
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
BioSpace
Wed, 09/20/23 - 08:59 am
Amgen
Horizon Therapeutics
FTC
antitrust
M&A
Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe
Reuters
Wed, 09/20/23 - 08:40 am
Oxford BioMedica
M&A
viral vectors
ABL Europe
cell therapy
Boston Scientific to buy chronic back pain therapy maker Relievant
Reuters
Tue, 09/19/23 - 10:33 am
M&A
Medtech
Boston Scientific
Relievant Medsystems
chronic back pain
Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder
Clinical Trials Arena
Fri, 09/15/23 - 11:31 am
Abcam
Danaher
M&A
FTC, amid biopharma M&A drive, says it will take action against 'sham' patents
Fierce Pharma
Fri, 09/15/23 - 11:21 am
FTC
M&A
patents
GE Healthcare's Independence, Acquisitions, & Bright Future
Medical Devices and Diagnostics Industry
Wed, 09/13/23 - 06:16 pm
Medtech
GE Healthcare
Jan Makela
M&A
Bausch + Lomb seeks funding for eye drug acquisition from Novartis
BioPharma Dive
Wed, 09/13/23 - 11:32 am
Bausch + Lomb
Novartis
M&A
Xiidra
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
Kriya, flush with funding, buys a gene therapy for NASH
BioPharma Dive
Thu, 09/7/23 - 10:51 pm
Kriya Therapeutics
gene therapy
NASH
M&A
Tramontane Therapeutics
Abbott and Bigfoot Take Relationship to the Next Level
Medical Devices and Diagnostics Industry
Tue, 09/5/23 - 08:49 pm
Abbott Labs
Bigfoot Biomedical
M&A
Medtech
diabetes
Years after $2B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia
Fierce Pharma
Tue, 09/5/23 - 11:32 am
Nestle
Palforzia
peanut allergy
M&A
Stallergenes Greer
FTC allows Amgen’s $27.8B purchase of Horizon to proceed
Medical Marketing and Media
Fri, 09/1/23 - 12:40 pm
FTC
Amgen
Horizon Therapeutics
M&A
Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower
Fierce Pharma
Wed, 08/30/23 - 11:29 pm
JNJ
M&A
consumer health
Kenvue
Novo Bolsters Obesity Pipeline with Potential $500M Embark Biotech Buy
BioSpace
Wed, 08/30/23 - 11:22 am
Novo Nordisk
Embark Biotech
obesity
M&A
FTC Temporarily Withdraws Challenge to $27.8B Amgen-Horizon Deal
BioSpace
Mon, 08/28/23 - 12:06 pm
FTC
Amgen
Horizon Therapeutics
M&A
After Catalent rumors, Danaher strikes $5.7B deal to acquire antibody specialist Abcam
Fierce Pharma
Mon, 08/28/23 - 12:00 pm
Danaher
Abcam
antibodies
M&A
'Far too speculative': Amgen fights FTC's request for injunction against $28B Horizon merger
Fierce Pharma
Thu, 08/24/23 - 11:38 am
Amgen
Horizon Therapeutics
M&A
FTC

Pages